Literature DB >> 19570116

Vascular risk screening: possible or too much, too soon?

A S Wierzbicki1, T M Reynolds.   

Abstract

Mesh：

Year:  2009        PMID： 19570116     DOI： 10.1111/j.1742-1241.2009.02111.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN： 1368-5031            Impact factor:   2.503


× No keyword cloud information.
  2 in total

1.  Cardiovascular risk evaluation and antiretroviral therapy effects in an HIV cohort: implications for clinical management: the CREATE 1 study.

Authors:  M Aboud; A Elgalib; L Pomeroy; G Panayiotakopoulos; E Skopelitis; R Kulasegaram; C Dimian; F C Lampe; A Duncan; A S Wierzbicki; B S Peters
Journal:  Int J Clin Pract       Date:  2010-08       Impact factor: 2.503

2.  Prediction of Cardiovascular Disease Risk Using Framingham and Data on Adverse Effect of Antiretroviral Drugs Risk Equation in Relation to Lipodystrophy in HIV Patients on Highly Active Antiretroviral Therapy.

Authors:  Deepak Kumar; Gopal Krishna Bohra; Madhulata Agarwal; Sayendra Khichar; Shyama Choudhary; Naresh Midha
Journal:  J Glob Infect Dis       Date:  2018 Oct-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.